» Articles » PMID: 35735171

Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers

Overview
Journal Medeni Med J
Specialty General Medicine
Date 2022 Jun 23
PMID 35735171
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to demonstrate the diagnostic value of microarray testing in autism spectrum disorder, intellectual disability, and multiple congenital anomalies of unknown etiology, as well as to report some potential candidate genes for autism.

Methods: Microarray analysis records between January 2016 and December 2017 from two Genetic Diagnostic Centers in Turkey, Kanuni Sultan Suleyman and Adana Numune Training and Research Hospital, were compiled. Detected copy number variations (CNVs) were classified as benign, likely benign, variants of uncertain significance (VUS), likely pathogenic, and pathogenic according to American College of Medical Genetics and Genomics guidelines. The clinical findings of the some patients and the literature data were compared.

Results: In 109 (24.5%) of 445 patients, a total of 163 CNVs with reporting criterion feature were detected. Sixty-nine (42%) and 8 (5%) of these were evaluated as pathogenic and likely pathogenic, respectively. Fifteen (9%) CNVs were also evaluated as VUS. Pathogenic or likely pathogenic CNVs were detected in 61 (13.6%) of 445 patients.

Conclusions: We found that the probability of elucidating the etiology of microarray method in autism spectrum disorder, intellectual disability, and multiple congenital anomalies is 13.6% with a percentage similar to the literature. We suggest that the , and genes are all strong candidate genes for autism spectrum disorders. We detailed the clinical findings of the cases and reported that some CNV regions in the genome may be associated with autism.

Citing Articles

Chromosome 15q11-q13 Duplication Syndrome: A Review of the Literature and 14 New Cases.

Bisba M, Malamaki C, Constantoulakis P, Vittas S Genes (Basel). 2024; 15(10).

PMID: 39457428 PMC: 11507414. DOI: 10.3390/genes15101304.

References
1.
Heilstedt H, Ballif B, Howard L, Kashork C, Shaffer L . Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality. Clin Genet. 2003; 64(4):310-6. DOI: 10.1034/j.1399-0004.2003.00126.x. View

2.
Rooney Riggs E, Andersen E, Cherry A, Kantarci S, Kearney H, Patel A . Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2019; 22(2):245-257. PMC: 7313390. DOI: 10.1038/s41436-019-0686-8. View

3.
Ou Z, Stankiewicz P, Xia Z, Breman A, Dawson B, Wiszniewska J . Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes. Genome Res. 2011; 21(1):33-46. PMC: 3012924. DOI: 10.1101/gr.111609.110. View

4.
Mefford H, Rosenfeld J, Shur N, Slavotinek A, Cox V, Hennekam R . Further clinical and molecular delineation of the 15q24 microdeletion syndrome. J Med Genet. 2011; 49(2):110-8. PMC: 3261729. DOI: 10.1136/jmedgenet-2011-100499. View

5.
Tokutomi T, Wada T, Nakagawa E, Saitoh S, Sasaki M . A de novo direct duplication of 16q22.1 --> q23.1 in a boy with midface hypoplasia and mental retardation. Am J Med Genet A. 2009; 149A(11):2560-3. DOI: 10.1002/ajmg.a.33049. View